Euro-Pharmacies GHRP-2 1 vial (5 mg)

GHRP-2 (growth hormone-releasing peptide 2)

also known as pralmorelin, is a potent GHS (growth hormone secretagogue) serving as a diagnostic agent. This class of compounds stimulates the secretion of GH (growth hormone), significantly enhancing production levels. Notably, it surpasses other preparations within the GHRP category like Ipamorelin and GHRP-6 by approximately 30%. The mechanism of action correlates with the stimulation of the hypothalamus and pituitary gland, which can lead to a 7 to 15-fold increase in GH secretion—far exceeding the 2 to 3-fold increases achieved by other stimulants based on GABA or amino acid levels. The hypophysis, or pituitary gland, is a small endocrine gland situated at the brain’s center, weighing about 0.018 oz (0.5 grams). Its primary function entails regulating hormone production across various endocrine glands. The hypothalamus, part of the diencephalon, serves as the core of the ANS (autonomic nervous system), managing essential body functions such as blood circulation, metabolism, and hormone regulation, alongside influencing sleep patterns. Consequently, this peptide engages with growth hormone secretagogue receptors, resulting in increased appetite.

Résultats

The benefits of this preparation encompass several bodily functions, delivering enhancements such as:

• Enhanced GH stimulation.
• Liver protection.
• Improved skin quality.
• Promotion of linear growth in children and adolescents.
• Anti-inflammatory effects boosting immunity.
• Stronger bones.
• Fat loss.
• Cholesterol level reduction.
• Increased muscle mass.
• Heightened appetite.
• Enhanced power performance.

Dosage

Injections should be administered on an empty stomach, at least two hours post-meal and no less than 60 minutes before the next consumption. It is advisable to intake some carbohydrates and fats before the injection. To counteract age-related changes, a single daily injection is sufficient. The typical growth hormone-releasing peptide 2 cycle lasts from 1 to 2 months, followed by a 1 to 2-week rest period to prevent pituitary depletion.

• Recommended frequency: three times daily.
• Injection site: body fat around the stomach area.
• Recommended injection dosage: 100mcg-200mcg per use.